Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review.

dc.contributor.author	Onwuemene, Oluwatoyosi A
dc.contributor.author	Nnoruka, Chizoba I
dc.contributor.author	Patriquin, Christopher J
dc.contributor.author	Connelly-Smith, Laura S
dc.date.accessioned	2023-04-07T12:47:49Z
dc.date.available	2023-04-07T12:47:49Z
dc.date.issued	2022-11
dc.date.updated	2023-04-07T12:47:48Z
dc.identifier.issn	0041-1132
dc.identifier.issn	1537-2995
dc.identifier.uri	https://hdl.handle.net/10161/27005
dc.language	eng
dc.publisher	Wiley
dc.relation.ispartof	Transfusion
dc.relation.isversionof	10.1111/trf.17114
dc.subject	Humans
dc.subject	Neoplasms
dc.subject	Plasma Exchange
dc.subject	Immunotherapy
dc.subject	Plasmapheresis
dc.subject	Immune Checkpoint Inhibitors
dc.title	Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review.
dc.type	Journal article
duke.contributor.orcid	Onwuemene, Oluwatoyosi A\|0000-0001-7266-7101
pubs.begin-page	2370
pubs.end-page	2390
pubs.issue	11
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, Hematology
pubs.publication-status	Published
pubs.volume	62

Files

Now showing 1 - 1 of 1